标题
Therapeutic targeting of the hypoxic tumour microenvironment
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-29
DOI
10.1038/s41571-021-00539-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase III Multi-Center, Prospective, Randomized Trial Comparing Single Dose 24 Gy Radiotherapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
- (2021) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
- (2021) Nicole E. Scharping et al. NATURE IMMUNOLOGY
- Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study
- (2021) Gabi U. Dachs et al. Frontiers in Oncology
- Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer
- (2021) Michael Skwarski et al. CLINICAL CANCER RESEARCH
- Superoxide produced by mitochondrial site IQ inactivates cardiac succinate dehydrogenase and induces hepatic steatosis in Sod2 knockout mice
- (2021) Hoi-Shan Wong et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
- (2021) McLane J. Watson et al. NATURE
- A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
- (2021) Aparna Hegde et al. CLINICAL CANCER RESEARCH
- Lost in application: Measuring hypoxia for radiotherapy optimisation
- (2021) Niluja Thiruthaneeswaran et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
- (2021) Toni K. Choueiri et al. NATURE MEDICINE
- Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
- (2021) Dan P Zandberg et al. Journal for ImmunoTherapy of Cancer
- Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease
- (2021) Volker H. Haase Kidney International Supplements
- Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia
- (2021) Luke W. Thomas et al. Communications Biology
- Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
- (2020) Pearl Lee et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tumor hypermetabolism confers resistance to immunotherapy
- (2020) Arthur Liu et al. SEMINARS IN CANCER BIOLOGY
- Divergent mutational processes distinguish hypoxic and normoxic tumours
- (2020) Vinayak Bhandari et al. Nature Communications
- A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
- (2020) Paul C. McDonald et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Genetic Screen for Cell Fitness in High or Low Oxygen Highlights Mitochondrial and Lipid Metabolism
- (2020) Isha H. Jain et al. CELL
- Radiation Damage to Tumor Vasculature Initiates a Program that Promotes Tumor Recurrences
- (2020) J. Martin Brown INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.
- (2020) Joyce F. Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia
- (2020) Blake A. Winn et al. JOURNAL OF NATURAL PRODUCTS
- Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)
- (2020) Ewen D.D. Calder et al. TETRAHEDRON
- Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib
- (2020) Bjoern Bielec et al. BIOORGANIC CHEMISTRY
- Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights
- (2020) Sachin Puri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
- (2020) Eva Bartok et al. IMMUNITY
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
- (2020) Jackie E. Bader et al. MOLECULAR CELL
- Oncometabolites suppress DNA repair by disrupting local chromatin signalling
- (2020) Parker L. Sulkowski et al. NATURE
- Na+ controls hypoxic signalling by the mitochondrial respiratory chain
- (2020) Pablo Hernansanz-Agustín et al. NATURE
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy
- (2020) Sebastian Zschaeck et al. RADIOTHERAPY AND ONCOLOGY
- Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma
- (2020) Zachary A. Bacigalupa et al. CANCER LETTERS
- The Role of HIF in Immunity and Inflammation
- (2020) Anne F. McGettrick et al. Cell Metabolism
- Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
- (2020) Stephen M. Hatfield et al. JOURNAL OF CLINICAL INVESTIGATION
- Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
- (2020) Chris P. Guise et al. MOLECULES
- Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)
- (2020) Mette Saksø et al. RADIOTHERAPY AND ONCOLOGY
- HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
- (2020) Rouven Hoefflin et al. Nature Communications
- Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
- (2020) Ashvin R. Jaiswal et al. Cancer Immunology Research
- 2-Nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche
- (2020) Naoyoshi Koike et al. Communications Biology
- Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
- (2020) Adriana Estrada-Bernal et al. CLINICAL CANCER RESEARCH
- Pharmacologic Targeting of Hypoxia-Inducible Factors
- (2019) Gregg L. Semenza Annual Review of Pharmacology and Toxicology
- Molecular landmarks of tumor hypoxia across cancer types
- (2019) Vinayak Bhandari et al. NATURE GENETICS
- Hypoxia induces rapid changes to histone methylation and reprograms chromatin
- (2019) Michael Batie et al. SCIENCE
- Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs
- (2019) R.K. Jackson et al. CLINICAL ONCOLOGY
- Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers
- (2019) Colles Price et al. CANCER RESEARCH
- Acidification of tumor at stromal boundaries drives transcriptome alterations associated with aggressive phenotypes
- (2019) Nazanin Rohani et al. CANCER RESEARCH
- Causes, consequences, and therapy of tumors acidosis
- (2019) Smitha R. Pillai et al. CANCER AND METASTASIS REVIEWS
- Prototyping kinase inhibitor-cytotoxin anticancer mutual prodrugs activated by tumour hypoxia: A chemical proof of concept study
- (2019) Geraud N. Sansom et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
- (2019) Silvia Pastorekova et al. CANCER AND METASTASIS REVIEWS
- Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non–small Cell Lung Cancer
- (2019) Ahmed Salem et al. CLINICAL CANCER RESEARCH
- Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma
- (2019) Daniel R. McGowan et al. EUROPEAN JOURNAL OF CANCER
- Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
- (2019) Paul C. McDonald et al. GASTROENTEROLOGY
- Hypoxia-active nanoparticles used in tumor theranostic
- (2019) Yaqin Wang et al. International Journal of Nanomedicine
- Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide
- (2019) Francis W. Hunter et al. MOLECULAR PHARMACOLOGY
- Studies Towards Hypoxia-Activated Prodrugs of PARP Inhibitors
- (2019) Benjamin D. Dickson et al. MOLECULES
- Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51
- (2019) Alanna R. Kaplan et al. Science Translational Medicine
- Targeting hypoxia-induced carbonic anhydrase IX enhances immune checkpoint blockade locally and systemically
- (2019) Shawn C Chafe et al. Cancer Immunology Research
- Hypoxia-induced VISTA promotes the suppressive function of myeloid- derived suppressor cells in the tumor microenvironment
- (2019) Jie Deng et al. Cancer Immunology Research
- Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy
- (2019) Magali Lecavalier-Barsoum et al. BRITISH JOURNAL OF CANCER
- Reduced CTL motility and activity in avascular tumor areas
- (2019) Yoav Manaster et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
- (2019) Jill M. Brooks et al. CLINICAL CANCER RESEARCH
- Impact of hypoxia on DNA repair and genome integrity
- (2019) Alanna R Kaplan et al. MUTAGENESIS
- Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy
- (2019) Steffen Löck et al. RADIOTHERAPY AND ONCOLOGY
- Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
- (2019) Norma Masson et al. SCIENCE
- The Natural Compound Climacostol as a Prodrug Strategy Based on pH Activation for Efficient Delivery of Cytotoxic Small Agents
- (2019) Elisabetta Catalani et al. Frontiers in Chemistry
- Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
- (2019) Asmaa El-Kenawi et al. BRITISH JOURNAL OF CANCER
- Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
- (2019) Reena P Thomas et al. CLINICAL CANCER RESEARCH
- Study of SHMT2 Inhibitors and Their Binding Mechanism by Computational Alanine Scanning
- (2019) Liping He et al. Journal of Chemical Information and Modeling
- Immunity, Hypoxia and Metabolism - the ménage à trois of cancer: implications for immunotherapy
- (2019) Carla Riera-Domingo et al. PHYSIOLOGICAL REVIEWS
- Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361
- (2019) Way Wua Wong et al. BIOCHEMICAL PHARMACOLOGY
- Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors
- (2019) Huiqiang Wei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- VISTA is an acidic pH-selective ligand for PSGL-1
- (2019) Robert J. Johnston et al. NATURE
- Carbonic anhydrase IX and acid transport in cancer
- (2019) Holger M. Becker BRITISH JOURNAL OF CANCER
- Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers
- (2019) Kaye J. Williams et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils
- (2019) Karim Mahiddine et al. JOURNAL OF CLINICAL INVESTIGATION
- Sumoylation of the histone demethylase KDM4A is required for binding to tumor suppressor p53 in HCT116 colon cancer cell lines
- (2018) Seung Eun Yu et al. Animal Cells and Systems
- In vitro evaluation of the monoclonal antibody 64 Cu-IgG M75 against human carbonic anhydrase IX and its in vivo imaging
- (2018) Adam Čepa et al. APPLIED RADIATION AND ISOTOPES
- Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
- (2018) Thomas M. Ashton et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
- (2018) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
- (2018) Shimpei Iikuni et al. Theranostics
- Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects
- (2018) Cho Rong Hong et al. BIOCHEMICAL PHARMACOLOGY
- Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo
- (2018) Shen-Han Lee et al. BRITISH JOURNAL OF CANCER
- Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
- (2018) Kevin D. Courtney et al. Cell Metabolism
- Unexpected pharmacokinetics of evofosfamide observed in phase III MAESTRO study.
- (2018) Jack P. Higgins et al. JOURNAL OF CLINICAL ONCOLOGY
- Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism
- (2018) Martin Benej et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systems analysis of intracellular pH vulnerabilities for cancer therapy
- (2018) Erez Persi et al. Nature Communications
- Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell Cultures
- (2018) Cho R. Hong et al. Frontiers in Pharmacology
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Beware of clinical trials of DNA repair inhibitors
- (2018) J Martin Brown INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury
- (2018) Sahra Bodo et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
- (2018) Elena Andreucci et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect
- (2018) Cho Rong Hong et al. NEOPLASIA
- In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1α Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor Model
- (2017) Azusa Maeda et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy
- (2017) Moana Tercel et al. JOURNAL OF MEDICINAL CHEMISTRY
- miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
- (2017) Min-Zu Wu et al. NATURE CELL BIOLOGY
- 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
- (2017) Parker L. Sulkowski et al. Science Translational Medicine
- Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability
- (2017) Jennifer M.J. Jongen et al. Oncotarget
- The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia
- (2017) Giusy Di Conza et al. Cell Reports
- Endothelial Progenitors: A Consensus Statement on Nomenclature
- (2017) Reinhold J. Medina et al. Stem Cells Translational Medicine
- Tris-base buffer: a promising new inhibitor for cancer progression and metastasis
- (2017) Arig Ibrahim-Hashim et al. Cancer Medicine
- Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells
- (2017) Shalini Sethumadhavan et al. PLoS One
- Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
- (2016) Francis W Hunter et al. BRITISH JOURNAL OF CANCER
- An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
- (2016) A. Ari Hakimi et al. CANCER CELL
- Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
- (2016) Roger M. Phillips CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces
- (2016) M. C. Lloyd et al. CANCER RESEARCH
- Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
- (2016) David Clever et al. CELL
- Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
- (2016) Gregg L Semenza EMBO JOURNAL
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- The impact of hypoxia on tumor-associated macrophages
- (2016) Anne-Theres Henze et al. JOURNAL OF CLINICAL INVESTIGATION
- O 2 sensing, mitochondria and ROS signaling: The fog is lifting
- (2016) Gregory B. Waypa et al. MOLECULAR ASPECTS OF MEDICINE
- miR-155 Overexpression Promotes Genomic Instability by Reducing High-fidelity Polymerase Delta Expression and Activating Error-Prone DSB Repair
- (2016) J. R. Czochor et al. MOLECULAR CANCER RESEARCH
- Peroxiredoxins in Regulation of MAPK Signalling Pathways; Sensors and Barriers to Signal Transduction
- (2016) MOLECULES AND CELLS
- Tumour hypoxia causes DNA hypermethylation by reducing TET activity
- (2016) Bernard Thienpont et al. NATURE
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate
- (2016) Petros A. Tyrakis et al. NATURE
- On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
- (2016) Hyejin Cho et al. NATURE
- Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs
- (2016) Liam J O'Connor et al. Nature Protocols
- The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
- (2016) Thomas M. Ashton et al. Nature Communications
- Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
- (2016) Gabriela Jiménez-Valerio et al. Cell Reports
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- (2016) Simon J. A. van Kuijk et al. Frontiers in Oncology
- pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates
- (2016) Kelly E. Burns et al. Scientific Reports
- Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole
- (2015) N C Dhani et al. BRITISH JOURNAL OF CANCER
- Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs
- (2015) F. W. Hunter et al. CANCER RESEARCH
- Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
- (2015) J. P. B. O'Connor et al. CANCER RESEARCH
- Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
- (2015) Shari Pilon-Thomas et al. CANCER RESEARCH
- Hypoxia Induces Production of L-2-Hydroxyglutarate
- (2015) Andrew M. Intlekofer et al. Cell Metabolism
- Hypoxia-Mediated Increases in l -2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress
- (2015) William M. Oldham et al. Cell Metabolism
- Quantitative and qualitative analysis of [18F]FDG and [18F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome
- (2015) Edward E. Graves et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
- (2015) Mitesh J. Borad et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9
- (2015) Yao Liu et al. JOURNAL OF HEPATOLOGY
- Suppressors of superoxide production from mitochondrial complex III
- (2015) Adam L Orr et al. Nature Chemical Biology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
- (2015) Haiquan Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New ways to image and target tumour hypoxia and its molecular responses
- (2015) Ludwig J. Dubois et al. RADIOTHERAPY AND ONCOLOGY
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5
- (2014) Jingli Wang et al. BIOCHEMICAL PHARMACOLOGY
- The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs
- (2014) Francis W. Hunter et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats
- (2014) M J Walters et al. BRITISH JOURNAL OF CANCER
- Is Indirect Cell Death Involved in Response of Tumors to Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy?
- (2014) Chang W. Song et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer
- (2014) Mateya E Trinkaus et al. Journal of Medical Imaging and Radiation Oncology
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer
- (2014) F. W. Hunter et al. MOLECULAR CANCER THERAPEUTICS
- Direct measurement of local oxygen concentration in the bone marrow of live animals
- (2014) Joel A. Spencer et al. NATURE
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
- (2014) Edward T. Chouchani et al. NATURE
- Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration
- (2014) Z Wen et al. ONCOGENE
- Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
- (2014) J. Ye et al. Cancer Discovery
- CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A
- (2013) Cindy Cazares-Körner et al. ACS Chemical Biology
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- Acidity Generated by the Tumor Microenvironment Drives Local Invasion
- (2013) V. Estrella et al. CANCER RESEARCH
- In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation
- (2013) Paulo A. Gameiro et al. Cell Metabolism
- SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase
- (2013) Murilo TD Bueno et al. Epigenetics
- Zinc Finger Nuclease Knock-out of NADPH:Cytochrome P450 Oxidoreductase (POR) in Human Tumor Cell Lines Demonstrates That Hypoxia-activated Prodrugs Differ in POR Dependence
- (2013) Jiechuang Su et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two phases of disulfide bond formation have differing requirements for oxygen
- (2013) Marianne Koritzinsky et al. JOURNAL OF CELL BIOLOGY
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- PERK/eIF2 signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS
- (2013) K. M. Rouschop et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Roles of Reactive Oxygen Species and Autophagy in Mediating the Tolerance of Tumor Cells to Cycling Hypoxia
- (2013) Marianne Koritzinsky et al. SEMINARS IN RADIATION ONCOLOGY
- Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival
- (2012) Luke R. G. Pike et al. BIOCHEMICAL JOURNAL
- Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer
- (2012) Veronique M. Neumeister et al. BREAST CANCER RESEARCH AND TREATMENT
- A Strategy for Selective O6-Alkylguanine-DNA Alkyltransferase Depletion Under Hypoxic Conditions
- (2012) Philip G. Penketh et al. Chemical Biology & Drug Design
- Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
- (2012) Geert O. Janssens et al. JOURNAL OF CLINICAL ONCOLOGY
- The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells
- (2012) Tor-Christian Aase Johannessen et al. NEURO-ONCOLOGY
- Oxygen Gas-Filled Microparticles Provide Intravenous Oxygen Delivery
- (2012) J. N. Kheir et al. Science Translational Medicine
- Passing the baton: the HIF switch
- (2012) Mei Yee Koh et al. TRENDS IN BIOCHEMICAL SCIENCES
- Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
- (2011) K. Toustrup et al. CANCER RESEARCH
- Chromatin as an oxygen sensor and active player in the hypoxia response
- (2011) Andrew Melvin et al. CELLULAR SIGNALLING
- The 2-Nitroimidazole EF5 Is a Biomarker for Oxidoreductases That Activate the Bioreductive Prodrug CEN-209 under Hypoxia
- (2011) J. Wang et al. CLINICAL CANCER RESEARCH
- Clinical trials of antioxidants as cancer prevention agents: Past, present, and future
- (2011) Michael Goodman et al. FREE RADICAL BIOLOGY AND MEDICINE
- Carbonic Anhydrase IX Interacts with Bicarbonate Transporters in Lamellipodia and Increases Cell Migration via Its Catalytic Domain
- (2011) Eliska Svastova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
- (2011) Fabio Pacchiano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hypoxia Triggers AMPK Activation through Reactive Oxygen Species-Mediated Activation of Calcium Release-Activated Calcium Channels
- (2011) P. T. Mungai et al. MOLECULAR AND CELLULAR BIOLOGY
- Hypoxia Leads to Na,K-ATPase Downregulation via Ca2+ Release-Activated Ca2+ Channels and AMPK Activation
- (2011) G. A. Gusarova et al. MOLECULAR AND CELLULAR BIOLOGY
- Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
- (2011) F. Meng et al. MOLECULAR CANCER THERAPEUTICS
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- Reductive carboxylation supports growth in tumour cells with defective mitochondria
- (2011) Andrew R. Mullen et al. NATURE
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
- (2011) Christian M. Metallo et al. NATURE
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of -ketoglutarate to citrate to support cell growth and viability
- (2011) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis
- (2011) Jens Overgaard RADIOTHERAPY AND ONCOLOGY
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
- (2010) C. P. Guise et al. CANCER RESEARCH
- Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability
- (2010) I. M. Pires et al. CANCER RESEARCH
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors
- (2010) K. O. Hicks et al. CLINICAL CANCER RESEARCH
- Targeting Hypoxic Cells through the DNA Damage Response
- (2010) M. Olcina et al. CLINICAL CANCER RESEARCH
- Differential activation and antagonistic function of HIF- isoforms in macrophages are essential for NO homeostasis
- (2010) N. Takeda et al. GENES & DEVELOPMENT
- Stereotactic Ablative Radiotherapy Should Be Combined With a Hypoxic Cell Radiosensitizer
- (2010) J. Martin Brown et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionation Results in Reduced Tumor Cell Kill Compared to Conventional Fractionation for Tumors With Regions of Hypoxia
- (2010) David J. Carlson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
- (2010) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
- (2010) Lester J. Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Erratum: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2010) Lenny Dang et al. NATURE
- Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130
- (2010) D. C. Hegan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
- (2009) I. F. Robey et al. CANCER RESEARCH
- Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A
- (2009) Y. Gu et al. MOLECULAR CANCER THERAPEUTICS
- Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
- (2009) Mark W. Dewhirst RADIATION RESEARCH
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells
- (2008) G-One Ahn et al. CANCER CELL
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Chronic Hypoxia Decreases Synthesis of Homologous Recombination Proteins to Offset Chemoresistance and Radioresistance
- (2008) N. Chan et al. CANCER RESEARCH
- Amplifying tumour-specific replication lesions by DNA repair inhibitors – A new era in targeted cancer therapy
- (2008) Thomas Helleday EUROPEAN JOURNAL OF CANCER
- Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: Long-term results of a placebo-controlled randomised study
- (2008) Katsuyuki Karasawa et al. RADIOTHERAPY AND ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now